Company Financials

United Therapeutics Corporation Financials

United States dollar

business United Therapeutics Corporation Company Profile

Main Stock Listing

NASDAQ: UTHR

Market Capitalization $22.46 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 18.48
Forward PE 16.72
Price to Sales TTM $7.04
Price to Book MRQ $3.17
Enterprise to Revenue 5.82
Enterprise to EBITDA 11.35

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 40.65%
Operating Margin 48.69%
Return on Assets TTM 13.14%
Return on Equity TTM 20.04%

Income Statement

Revenue TTM $3,128,399,872
Revenue per Share TTM $70.03
Quarterly Revenue Growth 6.80%
Gross Profit TTM $2,771,500,032
EBITDA $1,801,700,000
Net Income to Common TTM $1,271,699,968
Diluted EPS TTM $26.36
Quarterly Earnings Growth YoY 9.60%

Balance Sheet

Total Cash MRQ $2,767,600,128
Total Cash per Share MRQ $64.28
Total Debt MRQ $
Total Debt to Equity MRQ 0.00
Current Ratio MRQ 6.40
Book Value per Share MRQ $153.61

Cash Flow

Operating Cash Flow TTM $1,556,199,936
Levered Free Cash Flow TTM $734,612,480

UTHR Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 42,902,818
Float Shares 40,055,123
Avg 10 Volume 493,650
Avg 30 Volume None
Shares Short 2,100,836
Short Ratio 4.90
Short % of Shares 6.51%
% Held by Insiders 1.85%
% Held by Institutions 99.13%

Stock Price Summary

Beta 0.86
Fifty Two Week Low $266.98
Fifty Two Week High $519.99
Fifty Two Week Change 28.45%
Day 50 MA $472.42
Day 200 MA $364.94

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2009-09-23